Studies library

Search our studies library

Our research fuels scientific advancement and empowers healthcare professionals in the pharmaceutical industry. Explore our extensive library of stability studies, permeation studies, case studies, white papers, and more.

Name of study	APIs and strength	Base
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Wound Care Compounding Preparations	N/A	AlpaWash
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats	N/A	AlpaWash
Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals	N/A	AlpaWash
Case Report on the Effect of AlpaWash® on the Healing of a Post-surgical Wound in a Female Canine Initially Diagnosed with Pyometra	N/A	AlpaWash
How water activity can affect the stability of compounded non-sterile preparations	N/A	AlpaWash, CopaSil, Lipmax, Oleabase Plasticized, Ointment Base (Emulsifying), VersaPro Anhydrous Base, PolyPeg Suppository Base, SPG Supposi-Base, SPG Natural Supposi-Base, Witepsol H-15, CapsuBlend-H, CapsuBlend-P, CapsuBlend-S, Gum Base (Gelatin), Medi-RDT Base, Medi X-Tabb Base, NovaFilm Gel Base, Oral Mix Dry Alka, SF, Troche Base, Troche Base, NS, Chew-A-Treat (Compound A), Chew-A-Treat (Compound B), Chew-A-Treat (Compound C), Chew-A-Treat (Compound Kit A&B), Chew-A-Treat (Compound Kit A&C)
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs	Metronidazole, Theophylline, Levocarnitine	CapsuBlend-S, CapsuBlend-P, CapsuBlend-H
Antimicrobial Activity of Copaíba (Copaifera officinalis) and Pracaxi (Pentaclethra macrobola) Oils against Staphylococcus Aureus: Importance in Compounding for Wound Care	N/A	CopaSil
Prospective, Randomized, Double-Blind, Placebo-Controlled Study on Efficacy of Copaiba Oil in Silicone-Based Gel to Reduce Scar Formation	N/A	CopaSil
Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn-scar Management	N/A	CopaSil
Stability Evaluation of Minoxidil in Foamil Foam Base with Bracketing Study Design	Minoxidil	Foamil
Stability Assessment of Compounded Bracketed Estradiol 0.01-0.2%, Estriol 0.04-0.8%, Progesterone 1-20%, Testosterone 0.025-0.5% and DHEA 0.2-4% in Medisca HRT Cream Base	Estradiol, Estriol, Progesterone, Testosterone, DHEA	HRT Cream Base
Stability Assessment of Compounded Bracketed Estradiol 0.01-10% in Medisca HRT Cream Base	Estradiol	HRT Cream Base
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.25%, Estriol 0.025-0.25% and Testosterone 1-10% in Medisca HRT Cream Base	Estradiol, Estriol, Testoterone	HRT Cream Base
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5%, Estriol 0.025-0.5% and Progesterone 1-20% in Medisca HRT Cream Base	Estradiol, Estriol, Progesterone	HRT Cream Base
Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5% and Estriol 0.1-2% in Medisca HRT Cream Base	Estradiol, Estriol	HRT Cream Base
Stability Assessment of Compounded Bracketed Estriol 0.01-10% in Medisca HRT Cream Base	Estriol	HRT Cream Base
Stability Assessment of Compounded Bracketed Hydroquinone 2-10% in Medisca HRT Cream Base	Hydroquinone	HRT Cream Base
Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca HRT Cream Base	Progesterone	HRT Cream Base
Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca HRT Cream Base	Testosterone	HRT Cream Base
Homogenizing in Patient Applicating Device with MD Pump Adapter in MAZ Mixer	N/A	N/A

Rows per page

1 - 20

Speak to an expert today

Experience peace of mind our team of expert pharmaciasts. From regulatory compliance to subject matter expertise, we provide tailored solutions to meet your unique needs. Contact us today to find out how we can elevate your compounding practice.

Action

Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Wound Care Compounding Preparations

N/A

AlpaWash

Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats

N/A

AlpaWash

Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals

N/A

AlpaWash

Case Report on the Effect of AlpaWash® on the Healing of a Post-surgical Wound in a Female Canine Initially Diagnosed with Pyometra

N/A

AlpaWash

How water activity can affect the stability of compounded non-sterile preparations

N/A

AlpaWash, CopaSil, Lipmax, Oleabase Plasticized, Ointment Base (Emulsifying), VersaPro Anhydrous Base, PolyPeg Suppository Base, SPG Supposi-Base, SPG Natural Supposi-Base, Witepsol H-15, CapsuBlend-H, CapsuBlend-P, CapsuBlend-S, Gum Base (Gelatin), Medi-RDT Base, Medi X-Tabb Base, NovaFilm Gel Base, Oral Mix Dry Alka, SF, Troche Base, Troche Base, NS, Chew-A-Treat (Compound A), Chew-A-Treat (Compound B), Chew-A-Treat (Compound C), Chew-A-Treat (Compound Kit A&B), Chew-A-Treat (Compound Kit A&C)

In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs

Metronidazole, Theophylline, Levocarnitine

CapsuBlend-S, CapsuBlend-P, CapsuBlend-H

Antimicrobial Activity of Copaíba (Copaifera officinalis) and Pracaxi (Pentaclethra macrobola) Oils against Staphylococcus Aureus: Importance in Compounding for Wound Care

N/A

CopaSil

Prospective, Randomized, Double-Blind, Placebo-Controlled Study on Efficacy of Copaiba Oil in Silicone-Based Gel to Reduce Scar Formation

N/A

CopaSil

Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn-scar Management

N/A

CopaSil

Stability Evaluation of Minoxidil in Foamil Foam Base with Bracketing Study Design

Minoxidil

Foamil

Stability Assessment of Compounded Bracketed Estradiol 0.01-0.2%, Estriol 0.04-0.8%, Progesterone 1-20%, Testosterone 0.025-0.5% and DHEA 0.2-4% in Medisca HRT Cream Base

Estradiol, Estriol, Progesterone, Testosterone, DHEA

HRT Cream Base

Stability Assessment of Compounded Bracketed Estradiol 0.01-10% in Medisca HRT Cream Base

Estradiol

HRT Cream Base

Stability Assesment of Compounded Bracketed Estradiol 0.025-0.25%, Estriol 0.025-0.25% and Testosterone 1-10% in Medisca HRT Cream Base

Estradiol, Estriol, Testoterone

HRT Cream Base

Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5%, Estriol 0.025-0.5% and Progesterone 1-20% in Medisca HRT Cream Base

Estradiol, Estriol, Progesterone

HRT Cream Base

Stability Assesment of Compounded Bracketed Estradiol 0.025-0.5% and Estriol 0.1-2% in Medisca HRT Cream Base

Estradiol, Estriol

HRT Cream Base

Stability Assessment of Compounded Bracketed Estriol 0.01-10% in Medisca HRT Cream Base

Estriol

HRT Cream Base

Stability Assessment of Compounded Bracketed Hydroquinone 2-10% in Medisca HRT Cream Base

Hydroquinone

HRT Cream Base

Stability Assessment of Compounded Bracketed Progesterone 1-40% in Medisca HRT Cream Base

Progesterone

HRT Cream Base

Stability Assessment of Compounded Bracketed Testosterone 0.02-25% in Medisca HRT Cream Base

Testosterone

HRT Cream Base

Homogenizing in Patient Applicating Device with MD Pump Adapter in MAZ Mixer

N/A